Beta Bionics (BBNX) Current Assets (2023 - 2026)

Beta Bionics' Current Assets history runs 4 years deep, the most recent figure standing at $248.0 million for Q1 2026.

• In Q1 2026, Current Assets fell 5.32% year-over-year to $248.0 million; the TTM figure through Mar 2026 stood at $248.0 million (down 5.32% YoY), while the FY2025 annual figure was $267.9 million, up 101.55% from the prior year.
• Current Assets came in at $248.0 million for Q1 2026 at Beta Bionics, down from $267.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $286.1 million in Q2 2025 to a low of $103.6 million in Q4 2023.
• A 4-year average of $224.4 million and a median of $261.9 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 101.55% in 2025 and declined 5.32% in 2026, its largest moves.
• Beta Bionics' Current Assets stood at $103.6 million in 2023, then grew by 28.28% to $132.9 million in 2024, then surged by 101.55% to $267.9 million in 2025, then slipped by 7.44% to $248.0 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $248.0 million, $267.9 million, and $270.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison